Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Innovative models to explore hepatic involvement in Prader-Willi syndrome.

Frontiers in endocrinology·2026
Same author

Subtype-dependent PD-L1 stability and immune context shape immunotherapy response in hepatocellular carcinoma.

Frontiers in immunology·2026
Same author

Inflammatory Proteomic Heterogeneity Beyond Glycemia Status in Severe Obesity.

International journal of molecular sciences·2026
Same author

The Role of ER Stress in Bilirubin Neurotoxicity: A Complex Molecular Network.

Antioxidants (Basel, Switzerland)·2026
Same author

A Descriptive Analysis of Mediterranean Diet Meal Plans Using the Dietary Inflammatory Index, Dietary Antioxidant Index, and Dietary Lipid Indices: Implications for Dietary Intervention for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Research.

Nutrients·2026
Same author

Fibulin-3 as a reliable biomarker of fibrosis in obese subjects with metabolic dysfunction-associated steatotic liver disease.

Annals of hepatology·2026

Related Experiment Video

Updated: May 29, 2026

Inducing Acute Liver Injury in Rats via Carbon Tetrachloride (CCl4) Exposure Through an Orogastric Tube
06:12

Inducing Acute Liver Injury in Rats via Carbon Tetrachloride (CCl4) Exposure Through an Orogastric Tube

Published on: April 28, 2020

Bilirubin-induced neurological damage.

Silvia Gazzin1, Claudio Tiribelli

  • 1Center of Liver Diseases, Italian Liver Foundation, and Medical Science's Department, University of Trieste, Italy.

The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
|September 28, 2011
PubMed
Summary

Severe neonatal jaundice causes increasing neurological damage, but its molecular causes are unknown. This review explores how bilirubin may harm specific brain cells, aiding diagnostic and therapeutic strategies.

More Related Videos

Assessment of Blood-brain Barrier Permeability by Intravenous Infusion of FITC-labeled Albumin in a Mouse Model of Neurodegenerative Disease
07:22

Assessment of Blood-brain Barrier Permeability by Intravenous Infusion of FITC-labeled Albumin in a Mouse Model of Neurodegenerative Disease

Published on: November 8, 2017

Sub-acute Cerebral Microhemorrhages Induced by Lipopolysaccharide Injection in Rats
06:39

Sub-acute Cerebral Microhemorrhages Induced by Lipopolysaccharide Injection in Rats

Published on: October 17, 2018

Related Experiment Videos

Last Updated: May 29, 2026

Inducing Acute Liver Injury in Rats via Carbon Tetrachloride (CCl4) Exposure Through an Orogastric Tube
06:12

Inducing Acute Liver Injury in Rats via Carbon Tetrachloride (CCl4) Exposure Through an Orogastric Tube

Published on: April 28, 2020

Assessment of Blood-brain Barrier Permeability by Intravenous Infusion of FITC-labeled Albumin in a Mouse Model of Neurodegenerative Disease
07:22

Assessment of Blood-brain Barrier Permeability by Intravenous Infusion of FITC-labeled Albumin in a Mouse Model of Neurodegenerative Disease

Published on: November 8, 2017

Sub-acute Cerebral Microhemorrhages Induced by Lipopolysaccharide Injection in Rats
06:39

Sub-acute Cerebral Microhemorrhages Induced by Lipopolysaccharide Injection in Rats

Published on: October 17, 2018

Area of Science:

  • Neuroscience
  • Neonatalogy
  • Toxicology

Background:

  • Severe neonatal jaundice is a growing concern, linked to early hospital discharge.
  • The precise molecular mechanisms underlying bilirubin-induced neurotoxicity remain largely unelucidated.
  • Understanding these mechanisms is critical for managing this condition.

Purpose of the Study:

  • To review current knowledge on bilirubin's neurotoxic effects.
  • To identify gaps in understanding the molecular basis of brain damage in neonatal jaundice.
  • To provide a foundation for developing new diagnostic and therapeutic approaches.

Main Methods:

  • Literature review and synthesis of existing research.
  • Analysis of studies investigating bilirubin's cellular and molecular actions.
  • Identification of vulnerable brain regions and mechanisms of damage.

Main Results:

  • Bilirubin, a byproduct of red blood cell breakdown, can cross the blood-brain barrier at high concentrations.
  • Specific neuronal populations in areas like the basal ganglia and hippocampus are particularly susceptible.
  • Mechanisms involve oxidative stress, mitochondrial dysfunction, and excitotoxicity.

Conclusions:

  • While bilirubin's neurotoxicity is established, precise molecular pathways require further investigation.
  • Targeting bilirubin metabolism or its downstream effects may offer therapeutic benefits.
  • Further research is essential for improved clinical management of neonatal jaundice.